Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Oncology Drugs Market, by Indication
1.4.2 Asia Pacific Oncology Drugs Market, by Drug Class Type
1.4.3 Asia Pacific Oncology Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2019, Mar – 2023, Nov) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. Asia Pacific Oncology Drugs Market by Indication
5.1 Asia Pacific Breast Cancer Market by Country
5.2 Asia Pacific Prostate Cancer Market by Country
5.3 Asia Pacific Lung Cancer Market by Country
5.4 Asia Pacific Stomach Cancer Market by Country
5.5 Asia Pacific Colorectal Cancer Market by Country
5.6 Asia Pacific Liver Cancer Market by Country
5.7 Asia Pacific Esophagus Cancer Market by Country
5.8 Asia Pacific Cervical Cancer Market by Country
5.9 Asia Pacific Kidney Cancer Market by Country
5.10. Asia Pacific Bladder Cancer Market by Country
5.11 Asia Pacific Other Cancer Market by Country
Chapter 6. Asia Pacific Oncology Drugs Market by Drug Class Type
6.1 Asia Pacific Targeted Therapy Market by Country
6.2 Asia Pacific Immunotherapy (Biologic Therapy) Market by Country
6.3 Asia Pacific Chemotherapy Market by Country
6.4 Asia Pacific Hormonal Therapy Market by Country
Chapter 7. Asia Pacific Oncology Drugs Market by Country
7.1 China Oncology Drugs Market
7.1.1 China Oncology Drugs Market by Indication
7.1.2 China Oncology Drugs Market by Drug Class Type
7.2 Japan Oncology Drugs Market
7.2.1 Japan Oncology Drugs Market by Indication
7.2.2 Japan Oncology Drugs Market by Drug Class Type
7.3 India Oncology Drugs Market
7.3.1 India Oncology Drugs Market by Indication
7.3.2 India Oncology Drugs Market by Drug Class Type
7.4 South Korea Oncology Drugs Market
7.4.1 South Korea Oncology Drugs Market by Indication
7.4.2 South Korea Oncology Drugs Market by Drug Class Type
7.5 Singapore Oncology Drugs Market
7.5.1 Singapore Oncology Drugs Market by Indication
7.5.2 Singapore Oncology Drugs Market by Drug Class Type
7.6 Malaysia Oncology Drugs Market
7.6.1 Malaysia Oncology Drugs Market by Indication
7.6.2 Malaysia Oncology Drugs Market by Drug Class Type
7.7 Rest of Asia Pacific Oncology Drugs Market
7.7.1 Rest of Asia Pacific Oncology Drugs Market by Indication
7.7.2 Rest of Asia Pacific Oncology Drugs Market by Drug Class Type
Chapter 8. Company Profiles
8.1 AbbVie, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Amgen, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Astellas Pharma, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 AstraZeneca PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.6 SWOT Analysis
8.5 Bristol Myers Squibb Company
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Acquisition and Mergers:
8.5.6 SWOT Analysis
8.6 F. Hoffmann-La Roche Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Johnson & Johnson
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental & Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.7.6 SWOT Analysis
8.8 Novartis AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.6 SWOT Analysis
8.9 Merck & Co., Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.5.2 Acquisition and Mergers:
8.9.6 SWOT Analysis
8.10. Pfizer, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional & Segmental Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.6 SWOT Analysis



List of Figures

FIG 1 Methodology for the research
FIG 2 Asia Pacific Oncology Drugs Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Oncology Drugs Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2019, Mar – 2023, Nov) Leading Players
FIG 7 Porter’s Five Forces Analysis - Oncology Drugs Market
FIG 8 Asia Pacific Oncology Drugs Market share by Indication, 2022
FIG 9 Asia Pacific Oncology Drugs Market share by Indication, 2030
FIG 10 Asia Pacific Oncology Drugs Market by Indication, 2019 - 2030, USD Million
FIG 11 Asia Pacific Oncology Drugs Market share by Drug Class Type, 2022
FIG 12 Asia Pacific Oncology Drugs Market share by Drug Class Type, 2030
FIG 13 Asia Pacific Oncology Drugs Market by Drug Class Type, 2019 - 2030, USD Million
FIG 14 Asia Pacific Oncology Drugs Market share by Country, 2022
FIG 15 Asia Pacific Oncology Drugs Market share by Country, 2030
FIG 16 Asia Pacific Oncology Drugs Market by Country, 2019 - 2030, USD Million
FIG 17 Recent strategies and developments: AbbVie, Inc.
FIG 18 Swot Analysis: AbbVie, Inc.
FIG 19 Swot Analysis: Amgen, Inc.
FIG 20 Recent strategies and developments: Astellas Pharma, Inc.
FIG 21 SWOT Analysis: Astellas Pharma, Inc.
FIG 22 Recent strategies and developments: AstraZeneca PLC
FIG 23 SWOT Analysis: AstraZeneca PLC
FIG 24 Recent strategies and developments: Bristol Myers Squibb Company
FIG 25 SWOT Analysis: Bristol Myers Squibb Company
FIG 26 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 27 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 28 Recent strategies and developments: Johnson & Johnson
FIG 29 Swot Analysis: Johnson & Johnson
FIG 30 SWOT Analysis: Novartis AG
FIG 31 Recent strategies and developments: Merck & Co., Inc.
FIG 32 SWOT Analysis: Merck & Co., Inc.
FIG 33 SWOT Analysis: Pfizer, Inc.

List of Tables

TABLE 1 Asia Pacific Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Oncology Drugs Market
TABLE 4 Product Launches And Product Expansions– Oncology Drugs Market
TABLE 5 Acquisition and Mergers– Oncology Drugs Market
TABLE 6 Asia Pacific Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 7 Asia Pacific Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 8 Asia Pacific Breast Cancer Market by Country, 2019 - 2022, USD Million
TABLE 9 Asia Pacific Breast Cancer Market by Country, 2023 - 2030, USD Million
TABLE 10 Asia Pacific Prostate Cancer Market by Country, 2019 - 2022, USD Million
TABLE 11 Asia Pacific Prostate Cancer Market by Country, 2023 - 2030, USD Million
TABLE 12 Asia Pacific Lung Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 13 Asia Pacific Lung Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 14 Asia Pacific Stomach Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 15 Asia Pacific Stomach Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 16 Asia Pacific Colorectal Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 17 Asia Pacific Colorectal Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 18 Asia Pacific Liver Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 19 Asia Pacific Liver Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 20 Asia Pacific Esophagus Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 21 Asia Pacific Esophagus Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 22 Asia Pacific Cervical Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 23 Asia Pacific Cervical Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 24 Asia Pacific Kidney Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 25 Asia Pacific Kidney Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 26 Asia Pacific Bladder Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 27 Asia Pacific Bladder Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 28 Asia Pacific Other Cancer Market by Country, 2019 - 2022, USD Million
TABLE 29 Asia Pacific Other Cancer Market by Country, 2023 - 2030, USD Million
TABLE 30 Asia Pacific Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 31 Asia Pacific Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 32 Asia Pacific Targeted Therapy Market by Country, 2019 - 2022, USD Million
TABLE 33 Asia Pacific Targeted Therapy Market by Country, 2023 - 2030, USD Million
TABLE 34 Asia Pacific Immunotherapy (Biologic Therapy) Market by Country, 2019 - 2022, USD Million
TABLE 35 Asia Pacific Immunotherapy (Biologic Therapy) Market by Country, 2023 - 2030, USD Million
TABLE 36 Asia Pacific Chemotherapy Market by Country, 2019 - 2022, USD Million
TABLE 37 Asia Pacific Chemotherapy Market by Country, 2023 - 2030, USD Million
TABLE 38 Asia Pacific Hormonal Therapy Market by Country, 2019 - 2022, USD Million
TABLE 39 Asia Pacific Hormonal Therapy Market by Country, 2023 - 2030, USD Million
TABLE 40 Asia Pacific Oncology Drugs Market by Country, 2019 - 2022, USD Million
TABLE 41 Asia Pacific Oncology Drugs Market by Country, 2023 - 2030, USD Million
TABLE 42 China Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 43 China Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 44 China Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 45 China Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 46 China Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 47 China Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 48 Japan Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 49 Japan Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 50 Japan Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 51 Japan Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 52 Japan Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 53 Japan Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 54 India Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 55 India Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 56 India Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 57 India Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 58 India Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 59 India Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 60 South Korea Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 61 South Korea Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 62 South Korea Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 63 South Korea Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 64 South Korea Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 65 South Korea Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 66 Singapore Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 67 Singapore Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 68 Singapore Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 69 Singapore Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 70 Singapore Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 71 Singapore Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 72 Malaysia Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 73 Malaysia Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 74 Malaysia Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 75 Malaysia Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 76 Malaysia Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 77 Malaysia Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 78 Rest of Asia Pacific Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 79 Rest of Asia Pacific Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 80 Rest of Asia Pacific Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 81 Rest of Asia Pacific Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 82 Rest of Asia Pacific Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 83 Rest of Asia Pacific Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 84 Key information – AbbVie, Inc.
TABLE 85 Key Information – Amgen, Inc.
TABLE 86 key information – Astellas Pharma, Inc.
TABLE 87 KEY INFORMATION – AstraZeneca PLC
TABLE 88 Key Information – Bristol Myers Squibb Company
TABLE 89 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 90 Key Information – Johnson & Johnson
TABLE 91 Key Information – Novartis AG
TABLE 92 Key Information - Merck & Co., Inc.
TABLE 93 Key Information – Pfizer, Inc.